App-Quantinova.ai

COMPARISON OF JNJ9375, A THROMBIN EXOSITE 1-DIRECTED ANTIBODY, WITH APIXABAN FOR THROMBOPROPHYLAXIS AFTER ELECTIVE KNEE REPLACEMENT SURGERY: TEXT-TKR STUDY

Jeffrey I. Weitz - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

apixaban

EXAMINING PRESCRIPTION DRUG ADHERENCE AND LONG-TERM OUTCOMES IN PATIENTS MANAGED MEDICALLY FOR ACUTE CORONARY SYNDROME

Razi Khan - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

GDF-15 IS ASSOCIATED WITH FUNCTIONAL CAPACITY & VENTRICULAR DYSFUNCTION IN PATIENTS WITH MODERATE TO SEVERE AORTIC STENOSIS & PRESERVED EJECTION FRACTION

Lauren Basmadjian - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Severe Aortic Stenosis

N/A

IDENTIFYING BIOMARKERS INDEPENDENTLY ASSOCIATED WITH SPONTANEOUS REPERFUSION IN ST ELEVATION MYOCARDIAL INFARCTION

Jay Shavadia - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

COMPARISON BETWEEN CARDIOVASCULAR TRIAL OUTCOMES AND TREATMENT EFFECTS USING CLINICAL ENDPOINT COMMITTEE ADJUDICATION VERSUS ROUTINE HEALTH DATA: A SYSTEMATIC REVIEW

Craig Rodrigues - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

ANTICOAGULANT USE AND THE RISK OF THROMBOEMBOLISM AND BLEEDING IN PATIENTS WITH NEW ATRIAL FIBRILLATION FOLLOWING NON-CARDIAC SURGERY

Malik Elharram - American College of Cardiology (ACC) , 2019

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Transient Ischemic Attack

N/A

The Presence of Cyanosis and the Volume of Intraoperative Transfusion Increase the Risk of Thrombosis in Neonates and Children Undergoing Cardiac Surgery

Usman Ali - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Congenital heart disease

N/A

Does Intranasal Insulin Administration in Surgical Patients Increase Insulin Levels in the Cerebrospinal Fluid?

Akiko Kawakami - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Cognitive dysfunction

Insulin human

Novel Point of Care Ultrasound Tool to Evaluate Obstructive Sleep Apnea Patients in the Perioperative Setting: A Feasibility Study

Mandeep Singh - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Mortality Associated with Post-operative Complications in Patients with Sleep Disordered Breathing

Rabail Chaudhry - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Perioperative Use of Gabapentinoids for the Management of Postoperative Acute Pain:a Systematic Review and Meta-analysis

Michael Verret - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Chronic pain

N/A

Effect of Intranasal Insulin on Glycemia and Delirium after Cardiac Surgery: A Pilot Study of Safety and Feasibility

Akiko Kawakami - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Postoperative delirium

Thiazolidinedione

Enhanced Cardio-respiratory Monitoring in the Postoperative Period Reduces Postoperative Cardio-pulmonary Complications in Patients Undergoing Bariatric Surgery

Mandeep Singh - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Pulmonary embolism

N/A

Feasibility Study for Screening and Testing Drug Allergies Preoperatively

David Holt - American Society of Anesthesiologists (ASA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

Penicillin

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer

C.N.Sternberg - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Metastatic castration-resistant prostate cancer

Radium-223 Dichloride

A phase I dose-escalation study of enzalutamide in combination with theÂ AKT inhibitor AZD5363 (capivasertib) in patients with metastatic castration-resistant prostate cancer

M.P.Kolinsky - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Enzalutamide

Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifenâ€”To Offer More? (aTTom) trial

J.M.S.Bartlett - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Tamoxifen

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

S.Gillessen - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Metastatic castration-resistant prostate cancer

N/A

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer

G.N.Hortobagyi - ESMO World Congress on Gastrointestinal Cancer (ESMO GI|ESMO WCGI) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Breast cancer

Ribociclib

PROMS, APPS AND EXERCISE IN DIABETES

Riddell M - Advanced Technologies and Treatments for Diabetes (ATTD) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

N/A

Filters

28841 Abstracts